NIH R01 · 2024
Abstract More than 790,000 patients undergo mechanical ventilation for acute respiratory failure (ARF) in the United States each year at a cost of $27 billion. The in-hospital mortality for these patients is nearly 35%, and for patients with critical illness, such as acute respiratory distress syndrome (ARDS), mortality can approach 50%. In some patients, guideline-appropriate care with lung-protective ventilation or prone positioning will save lives, yet in many others, an individualized treatment is elusive. There is a need for advances in leveraging opportunities in data science to improve outcomes from respiratory failure. The primary method for generating new evidence is the randomized…
From the public funding record at NIH RePORTER. Describes the funded project, not the reviews below.